The lean patient with type 2 diabetes: Characteristics and therapy challenge

International Journal of Clinical Practice

Volumn 61, Issue SUPPL. 153, 2007, Pages 3-9

  Brunetti, P ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; GLIMEPIRIDE; GLINIDE; INSULIN; METFORMIN; SULFONYLUREA; UNCLASSIFIED DRUG;

BODY MASS; CLINICAL PRACTICE; DRUG POTENTIATION; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; BODY WEIGHT; INSULIN RESISTANCE; SECRETION;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; THINNESS;

EID: 34347235521     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01359.x     Document Type: Review

References (59)

1. James WPT, Jackson-Leach R, Mhurdu CN et al. Overweight and obesity. In : Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva : WHO, 2003.
2. Diabetes Atlas (2nd Edn). International Diabetes Federation 2003. http://www.idf.org/e-atlas. Accessed on 14 April 2006.
3. National Heart, Lung, and Blood Institute Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998 6 (Suppl. 2 51S 209S.
4. Eberhardt MS, Ogden C. Prevalence of overweight and obesity among adults with diagnosed diabetes - United States, 1988-1994 and 1999-2002. Morb Mortal Wkly Rep 2004 53 : 1066 8.
5. Daousi C, Casson IF, Gill GV et al. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J 2006 82 : 280 4.
6. Mannucci E, Alegiani SS, Monami M et al. Indexes of abdominal adiposity in patients with type 2 diabetes. J Endocrinol Invest 2004 27 : 535 40.
7. Leibson CL, Williamson DF, Melton LJ III. et al. Temporal trends in BMI among adults with diabetes. Diabetes Care 2001 24 : 1584 9.
8. Cnop M, Landchild MJ, Vidal J et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002 51 : 1005 15.
9. Utzschneider KM, Carr DB, Hull RL et al. Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes 2004 53 : 2867 72.
10. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res 2003 11 : 1223 31.
11. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006 23 : 469 80.
12. Seidell JC, Kahn HS, Williamson DF et al. Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr 2001 73 : 123 6.
13. World Health Organization (WHO) Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004 363 : 157 63.
14. World Health Organization 2000. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. http://www.iotf.org/asiapacific/. Accessed on 16 April 2006.
15. Tseng CH. Body mass index and waist circumference as determinants of coronary artery disease in Taiwanese adults with type 2 diabetes mellitus. Int J Obes (Lond) 2006 30 : 816 21.
16. Lu B, Yang Y, Song X et al. An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism 2006 55 : 1088 96.
17. Deurenberg-Yap M, Schmidt G, van Staveren WA, Deurenberg P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord 2000 24 : 1011 7.
18. Vikram NK, Misra A, Pandey RM et al. Anthropometry and body composition in northern Asian Indian patients with type 2 diabetes: receiver operating characteristics (ROC) curve analysis of body mass index with percentage body fat as standard. Diabetes Nutr Metab 2003 16 : 32 40.
19. Kadowaki T, Sekikawa A, Murata K et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes (Lond) 2006 30 : 1163 5.
20. Tan CE, Ma S, Wai D et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians Diabetes Care 2004 27 : 1182 6.
21. James WP. Assessing obesity: are ethnic differences in body mass index and waist classification criteria justified Obes Rev 2005 6 : 179 81.
22. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002 66 : 987 92.
23. Zhou BF, Cooperative Meta-Analysis Group of the Working group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults - study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002 15 : 83 95.
24. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 2001 24 : 1522 7.
25. Goodpaster BH, Krishnaswami S, Resnick H et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003 26 : 372 9.
26. Fourlanos S, Dotta F, Greenbaum CJ et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005 48 : 2206 12.
27. Tuomi T, Carlsson A, Li H, Isomaa B et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999 48 : 150 7.
28. Turner R, Stratton I, Horton V et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997 350 : 1288 93.
29. Bruno G, De Salvia A, Arcari R et al. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Diabetes Care 1999 22 : 50 5.
30. Bogardus C, Lillioja S, Mott DM et al. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985 248 : E286 91.
31. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995 75 : 473 86.
32. Miyazaki Y, Glass L, Triplitt C et al. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002 283 : E1135 43.
33. Gastaldelli A, Baldi S, Pettiti M et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000 49 : 1367 73.
34. Gastaldelli A, Miyazaki Y, Pettiti M et al. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J Clin Endocrinol Metab 2004 89 : 3914 21.
35. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004 88 : 787 835.
36. Haffner SM, Howard G, Mayer E et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 1997 46 : 63 9.
37. Banerji MA, Lebovitz HE. Insulin action in black Americans with NIDDM. Diabetes Care 1992 15 : 1295 302.
38. Arner P, Pollare T, Lithell H. Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 1991 34 483 7.
39. García-Estévez DA, Araújo-Vilar D, Saavedra-González A et al. Glucose metabolism in lean patients with mild type 2 diabetes mellitus: evidence for insulin-sensitive and insulin-resistant variants. Metabolism 2002 51 : 1047 52.
40. Chang SA, Kim HS, Yoon KH et al. Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metabolism 2004 53 : 142 6.
41. Taniguchi A, Fukushima M, Sakai M et al. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism 2000 49 : 1001 5.
42. Chan WB, Tong PC, Chow CC et al. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients. Diabet Med 2004 21 : 349 53.
43. Prando R, Cheli V, Melga P et al. Is type 2 diabetes a different disease in obese and nonobese patients Diabetes Care 1998 21 : 1680 5.
44. Røder ME, Dinesen B, Hartling SG et al. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care 1999 22 : 609 14.
45. Kahn SE, Prigeon RL, McCulloch DK et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993 42 : 1663 72.
46. Gastaldelli A, Ferrannini E, Miyazaki Y et al. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004 47 : 31 9.
47. Matthews DR, Cull CA, Stratton IM et al. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 1998 15 : 297 303.
48. U.K. Prospective Diabetes Study Group. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group. Ann Intern Med 1998 128 : 165 75.
49. Butler AE, Janson J, Bonner-Weir S et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003 52 : 102 10.
50. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006 49 : 1711 21.
51. IDF Clinical Guidelines Task Force. Global Guidelines for Type 2 Diabetes. Brussels : International Diabetes Federation, 2005.
52. Del Prato S, Pulizzi N. The place of sulfonylureas in the therapy for type 2 diabetes mellitus. Metabolism 2006 55 (5 Suppl. 1 S20 7.
53. Johnsen SP, Monster TB, Olsen ML et al. Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugs. Am J Ther 2006 13 : 134 40.
54. Li Y, Hansotia T, Yusta B et al. Glucagon-like peptide-1 receptor signalling modulates beta cell apoptosis. J Biol Chem 2003 278 : 471 8.
55. Walter H, Lübben G. Potential role of oral thiazolidinedione therapy in preserving β-cell function in type 2 diabetes mellitus. Drugs 2005 65 : 1 13.
56. Del Guerra S, Marselli L, Lupi R et al. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets. J Diabetes Complicat 2005 19 : 60 4.
57. Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY. Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 2005 90 : 501 6.
58. Rustenbeck I, Krautheim A, Jörns A, Steinfelder HJ. β-cell toxicity of ATP-sensitive K+ channel-blocking insulin secretagogues. Biochem Pharmacol 2004 67 : 1733 41.
59. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995 44 : 1249 58.